Small Pharma to Participate in Upcoming September Investor Conferences
September 08, 2022 12:24 ET
|
Small Pharma Inc.
LONDON, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted...
Small Pharma Announces TSXV Approval of Normal Course Issuer Bid
August 18, 2022 07:50 ET
|
Small Pharma Inc.
LONDON, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted...
Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction Study
August 15, 2022 07:50 ET
|
Small Pharma Inc.
LONDON, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted...
Canadian Patent Grant Strengthens Small Pharma’s International Position
August 03, 2022 07:50 ET
|
Small Pharma Inc.
LONDON, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted...
U.S. Patent Grant to Strengthen Small Pharma’s DMT Patent Strategy With Injectable Formulation
July 26, 2022 07:50 ET
|
Small Pharma Inc.
Key U.S. patent protection on injectable delivery of DMT in lead programs SPL026 and SPL028 LONDON, July 26, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company”...
George Tziras to Succeed Peter Rands as Small Pharma Chief Executive Officer
July 18, 2022 07:50 ET
|
Small Pharma Inc.
Building on strong foundations to take Small Pharma through development to commercial success Peter Rands to take on role as Chief Innovation & Intellectual Property Officer LONDON,...
Small Pharma Reports Fiscal First Quarter 2023 Highlights
July 15, 2022 17:05 ET
|
Small Pharma Inc.
Progress continues apace with multiple trials expected to enter clinic later this year First US patent granted LONDON, July 15, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB:...
Small Pharma to Participate in the H.C. Wainwright 1st Annual Mental Health Conference on June 27, 2022
June 22, 2022 13:00 ET
|
Small Pharma Inc.
LONDON, United Kingdom, June 22, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting...
Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022
June 09, 2022 17:10 ET
|
Small Pharma Inc.
Reporting its financial results and continued progress across short-acting psychedelics portfolio Executive team and IP position strengthened LONDON, June 09, 2022 (GLOBE NEWSWIRE) -- Small Pharma...
Small Pharma To Present at the Jefferies Healthcare Conference in New York City on June 10, 2022
May 30, 2022 07:50 ET
|
Small Pharma Inc.
LONDON, May 30, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted...